Pasireotide LAR is significantly more effective than octreotide LAR at providing biochemical control in patients with acromegaly: Results of a 12-month randomized, double-blind, multicenter, phase III study

Authors
Category Primary study
JournalEndocrine Reviews
Year 2012
This article has no abstract
Epistemonikos ID: 7805aedaabb9f5cd2a76ac2f90a1206272c8ba9d
First added on: Feb 05, 2025